Evidence map›Paper›PMID 32408345›Full record

ReviewBrain : a journal of neurology2020

Neurofilaments: neurobiological foundations for biomarker applications.

Arie R Gafson, Nicolas R Barthélemy, Pascale Bomont, Roxana O Carare, Heather D Durham, Jean-Pierre Julien, Jens Kuhle, David Leppert, Ralph A Nixon, Roy O Weller and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Brain : a journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 203 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
203citing papers in PubMed, 6 pooled it
21.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

203 citing papers in PubMed, 6 syntheses or guidelines pooled it, 307 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

143 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 6 countries.

Arie R GafsonDepartment of Brain Sciences, Imperial College, London, UK.
Nicolas R BarthélemyDepartment of Neurology, Washington University School of Medicine, St Louis, MO, USA.
Pascale BomontATIP-Avenir team, INM, INSERM, Montpellier University, Montpellier, France.
Roxana O CarareClinical Neurosciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
Heather D DurhamDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.
Jean-Pierre JulienDepartment of Psychiatry and Neuroscience, Laval University, Quebec, Canada.
Jens KuhleNeurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
David LeppertNeurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Ralph A NixonCenter for Dementia Research, Nathan Kline Institute, Orangeburg, NY, 10962, USA.
Roy O WellerClinical Neurosciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
Henrik ZetterbergUniversity College London Queen Square Institute of Neurology, London, UK.
Paul M MatthewsDepartment of Brain Sciences, Imperial College, London, UK.
Southampton General Hospital · GBUniversity of Basel · CHImperial College London · GBInserm · FRMontreal Neurological Institute and Hospital · CANathan Kline Institute for Psychiatric Research · USSahlgrenska University Hospital · SEUK Dementia Research Institute · GBUniversité Laval · CAWashington University in St. Louis · US

Funding

Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal functionP01AG017617 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI NIXON, RALPH A. · 2000 to 2021
$40.0M
Medical Research Council G0900897Medical Research Council G9409531Medical Research Council G9409634Medical Research Council G9901399Medical Research Council MC_PC_17114Medical Research Council MR/K501013/1Medical Research Council MR/N026934/1NIA NIH HHS P01 AG017617
6 · The paper itself

Abstract

Interest in neurofilaments has risen sharply in recent years with recognition of their potential as biomarkers of brain injury or neurodegeneration in CSF and blood. This is in the context of a growing appreciation for the complexity of the neurobiology of neurofilaments, new recognition of specialized roles for neurofilaments in synapses and a developing understanding of mechanisms responsible for their turnover. Here we will review the neurobiology of neurofilament proteins, describing current understanding of their structure and function, including recently discovered evidence for their roles in synapses. We will explore emerging understanding of the mechanisms of neurofilament degradation and clearance and review new methods for future elucidation of the kinetics of their turnover in humans. Primary roles of neurofilaments in the pathogenesis of human diseases will be described. With this background, we then will review critically evidence supporting use of neurofilament concentration measures as biomarkers of neuronal injury or degeneration. Finally, we will reflect on major challenges for studies of the neurobiology of intermediate filaments with specific attention to identifying what needs to be learned for more precise use and confident interpretation of neurofilament measures as biomarkers of neurodegeneration.

Indexed as

BiomarkersIntermediate FilamentsNerve DegenerationSynapsesAnimalsHumansBiomarkersbiomarkersneurodegenerationneurofilamentsneuroinflammationtraumatic brain injury

Identifiers

PMID32408345
PMCPMC7363489
OpenAlexW3024239323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.